vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and SEMrush Holdings, Inc. (SEMR). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $117.7M, roughly 1.0× SEMrush Holdings, Inc.). Core Laboratories Inc. runs the higher net margin — 4.2% vs -9.4%, a 13.6% gap on every dollar of revenue. On growth, SEMrush Holdings, Inc. posted the faster year-over-year revenue change (14.6% vs -1.4%). SEMrush Holdings, Inc. produced more free cash flow last quarter ($14.8M vs $517.0K). Over the past eight quarters, SEMrush Holdings, Inc.'s revenue compounded faster (17.1% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Semrush Holdings, Inc. is an American public company that has a SaaS platform known as Semrush. The platform is used for keyword research, competitive analysis, site audits, backlink tracking, domain authority tracking, and online visibility insights. The keyword research tool provides various data points on each keyword. The platform also collects information about online keywords gathered from Google and Bing search engines. It was released by Boston-based company Semrush Inc, founded by Ol...

CLB vs SEMR — Head-to-Head

Bigger by revenue
CLB
CLB
1.0× larger
CLB
$121.8M
$117.7M
SEMR
Growing faster (revenue YoY)
SEMR
SEMR
+16.1% gap
SEMR
14.6%
-1.4%
CLB
Higher net margin
CLB
CLB
13.6% more per $
CLB
4.2%
-9.4%
SEMR
More free cash flow
SEMR
SEMR
$14.3M more FCF
SEMR
$14.8M
$517.0K
CLB
Faster 2-yr revenue CAGR
SEMR
SEMR
Annualised
SEMR
17.1%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
SEMR
SEMR
Revenue
$121.8M
$117.7M
Net Profit
$5.1M
$-11.1M
Gross Margin
80.4%
Operating Margin
1.5%
-11.8%
Net Margin
4.2%
-9.4%
Revenue YoY
-1.4%
14.6%
Net Profit YoY
-431.8%
EPS (diluted)
$0.11
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
SEMR
SEMR
Q1 26
$121.8M
Q4 25
$138.3M
$117.7M
Q3 25
$134.5M
$112.1M
Q2 25
$130.2M
$108.9M
Q1 25
$123.6M
$105.0M
Q4 24
$129.2M
$102.6M
Q3 24
$134.4M
$97.4M
Q2 24
$130.6M
$91.0M
Net Profit
CLB
CLB
SEMR
SEMR
Q1 26
$5.1M
Q4 25
$4.9M
$-11.1M
Q3 25
$14.2M
$-2.1M
Q2 25
$10.6M
$-6.6M
Q1 25
$-154.0K
$849.0K
Q4 24
$7.4M
$3.3M
Q3 24
$11.7M
$1.1M
Q2 24
$9.0M
$1.7M
Gross Margin
CLB
CLB
SEMR
SEMR
Q1 26
Q4 25
20.8%
80.4%
Q3 25
22.0%
80.2%
Q2 25
20.3%
80.6%
Q1 25
19.5%
81.1%
Q4 24
17.8%
81.7%
Q3 24
20.5%
82.5%
Q2 24
21.2%
83.6%
Operating Margin
CLB
CLB
SEMR
SEMR
Q1 26
1.5%
Q4 25
11.5%
-11.8%
Q3 25
15.6%
-4.0%
Q2 25
11.7%
-4.0%
Q1 25
3.6%
-0.1%
Q4 24
11.0%
1.7%
Q3 24
14.7%
1.8%
Q2 24
12.3%
3.7%
Net Margin
CLB
CLB
SEMR
SEMR
Q1 26
4.2%
Q4 25
3.6%
-9.4%
Q3 25
10.6%
-1.9%
Q2 25
8.2%
-6.0%
Q1 25
-0.1%
0.8%
Q4 24
5.7%
3.3%
Q3 24
8.7%
1.1%
Q2 24
6.9%
1.8%
EPS (diluted)
CLB
CLB
SEMR
SEMR
Q1 26
$0.11
Q4 25
$0.11
$-0.09
Q3 25
$0.30
$-0.01
Q2 25
$0.22
$-0.04
Q1 25
$0.00
$0.01
Q4 24
$0.15
$0.03
Q3 24
$0.25
$0.01
Q2 24
$0.19
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
SEMR
SEMR
Cash + ST InvestmentsLiquidity on hand
$22.8M
$264.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$288.6M
Total Assets
$587.7M
$454.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
SEMR
SEMR
Q1 26
$22.8M
Q4 25
$22.7M
$264.3M
Q3 25
$25.6M
$80.8M
Q2 25
$31.2M
$54.3M
Q1 25
$22.1M
$64.7M
Q4 24
$19.2M
$48.9M
Q3 24
$21.5M
$45.1M
Q2 24
$17.7M
$69.6M
Total Debt
CLB
CLB
SEMR
SEMR
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
SEMR
SEMR
Q1 26
$275.1M
Q4 25
$266.0M
$288.6M
Q3 25
$271.3M
$289.7M
Q2 25
$261.3M
$279.0M
Q1 25
$253.4M
$268.7M
Q4 24
$246.6M
$256.6M
Q3 24
$250.7M
$248.5M
Q2 24
$240.3M
$235.6M
Total Assets
CLB
CLB
SEMR
SEMR
Q1 26
$587.7M
Q4 25
$584.0M
$454.1M
Q3 25
$591.4M
$450.4M
Q2 25
$602.1M
$424.9M
Q1 25
$591.5M
$416.5M
Q4 24
$585.1M
$390.9M
Q3 24
$600.5M
$383.8M
Q2 24
$597.8M
$372.9M
Debt / Equity
CLB
CLB
SEMR
SEMR
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
SEMR
SEMR
Operating Cash FlowLast quarter
$4.0M
$14.9M
Free Cash FlowOCF − Capex
$517.0K
$14.8M
FCF MarginFCF / Revenue
0.4%
12.6%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$57.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
SEMR
SEMR
Q1 26
$4.0M
Q4 25
$7.9M
$14.9M
Q3 25
$8.5M
$21.9M
Q2 25
$13.9M
$684.0K
Q1 25
$6.7M
$22.1M
Q4 24
$20.6M
$11.9M
Q3 24
$13.1M
$8.1M
Q2 24
$17.1M
$12.1M
Free Cash Flow
CLB
CLB
SEMR
SEMR
Q1 26
$517.0K
Q4 25
$5.0M
$14.8M
Q3 25
$6.5M
$21.5M
Q2 25
$10.4M
$80.0K
Q1 25
$3.9M
$21.4M
Q4 24
$17.4M
$11.5M
Q3 24
$10.4M
$7.6M
Q2 24
$14.3M
$10.0M
FCF Margin
CLB
CLB
SEMR
SEMR
Q1 26
0.4%
Q4 25
3.6%
12.6%
Q3 25
4.8%
19.2%
Q2 25
8.0%
0.1%
Q1 25
3.1%
20.4%
Q4 24
13.4%
11.2%
Q3 24
7.7%
7.8%
Q2 24
10.9%
11.0%
Capex Intensity
CLB
CLB
SEMR
SEMR
Q1 26
Q4 25
2.1%
0.1%
Q3 25
1.5%
0.4%
Q2 25
2.7%
0.6%
Q1 25
2.3%
0.7%
Q4 24
2.5%
0.4%
Q3 24
2.0%
0.5%
Q2 24
2.2%
2.4%
Cash Conversion
CLB
CLB
SEMR
SEMR
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
Q2 25
1.31×
Q1 25
26.04×
Q4 24
2.78×
3.57×
Q3 24
1.12×
7.44×
Q2 24
1.90×
7.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons